期刊文献+

巨泌乳素干扰高泌乳素血症诊断的临床研究 被引量:7

The clinical research on the interference of macroprolactin on diagnosis in hyperprolactinemia
暂未订购
导出
摘要 目的:探讨高泌乳素血症中巨泌乳素(MPRL)对泌乳素(PRL)检测的干扰及应用聚乙二醇(PEG)筛查MPRL的可行性。方法:200例高泌乳素血症患者按临床表现和影像学资料分为垂体性高泌乳素血症组(100例)、功能性高泌乳素血症组(100例),正常对照组(100例)。采用拜耳ACS180全自动化学发光免疫检测仪检测各组血清PEG处理前、后的PRL值。以回收率≤40%为判断MPRL的临界值。结果:各组间血清PRL处理前、后结果有统计学差异(P<0.05);各组巨泌乳素血症发生率分别为3%、25%和1%。高泌乳素血症中巨泌乳素血症的总发生率为14%。高泌乳素血症患者含有MPRL,明显的影响PRL的检测。其中以功能性高泌乳素血症的影响较大。结论:应用PEG去除MPRL的干扰是可行的,它有助于临床高泌乳素血症的正确诊断和治疗。 Objective: To explore the existence of macroprolactin (MPRL) in the blood samples of patients with hyperprolactinemia(HPRL), determine the extent of MPRL interfere on prolactin (PRL) assay, and analyze the feasibility of applying polyethylene glycol (PEG) treatment in the screening test for MPRL. Methods: We classified 200 hyperprolactinemic patients ,on a clinical and imaging basis,into two groups:A pituitary lesions hyperprolactinemia; B functional hyperprolactinemia. And a control group was consisted of 100 healthy persons. PRL was measured by Bayer ACS 180 prior to and after PEG serum treament. A PRL recovery rate of ≤ 40% was an indication of macroprolactinemia. Results: The serum PRL levels measured between groups were significantly different before and after PEG treatment (P〈0.05).The incidence of macorprolactinemia of each group were 3% ,25% ,1%, respectively.The total incidence of macorprolactinemia in the HPRL was 14%. The presence of MPRL had influence on the determination of PRL, especially in functional hyperprolactinemia. Conclusion: The use of PEG immunoprecipitation procedure may be a particular important method that eliminates MPRL interference from PRL immunoassays.
出处 《天津医科大学学报》 2009年第4期639-641,共3页 Journal of Tianjin Medical University
关键词 高泌乳素血症 巨泌乳素 聚乙二醇 Hyperprolactinemia Macroprolactin Polyethylene glycol
  • 相关文献

参考文献11

  • 1张国祥,许文龙.巨泌乳素对高泌乳素血症患者泌乳素免疫分析的影响[J].标记免疫分析与临床,2007,14(3):167-170. 被引量:2
  • 2Schneider W,Marcowitz S,A1-Shammari S, et al.Reactivity of macro prolactin in common automated immunoassays[J]. Clin Biochem, 2001,34(6):469.
  • 3Smith TP, Kavanagh L, Healy ML, et al.Technology insight:measuring prolactin in clinical samples [J].Nat Clin Pract Endocrinol Metab, 2007,3(3):279.
  • 4Fahie-Wilson M N,Brunsden P,Surrey J, et al.Macroprolactin and the roche elecsys prolactin assay:Characteristics of the reaction and detection by precipitation with polyethylene glycol [J].Chin Chem, 2000,46(12):1993.
  • 5Leslie H,Courtney C H,Bell P M, et al.Laboratory and clinical experience in 55 patients with maeroprolactinemia identified by a sim- ple polyethylene glycol preeipetation method [J].Clin Endocrinol Metab,2001,86(6) :2743.
  • 6Fahie -Wilson M N,Soule S G.Macroprolactin:contribution to hyperprolactinacmia in a district general hospital and evaluation of a screening test based on precipitation with polyethlene glycol[J].Ann Clin Biochem, 1997,34 ( 3 ) :252.
  • 7Amadofi P,Dilberis C,Marcolla A, et al. Macroprolactinemia:predictability on clinical basis and detection by PEG precipitation with two different immunometric methods [J].Endecrinol Invest,2003,26 (2):148.
  • 8Fahie- Wilson M N. Polyethylene glycol precipetation as a screening method for macroprolactinemia[J].Clin Chem,1999,45 ( 2 ): 136.
  • 9张荣富,丁杰锋,屠凤娟.聚乙二醇沉淀样品预处理法在鉴别诊断巨催乳素血症中的应用[J].医学研究杂志,2008,37(4):103-105. 被引量:3
  • 10吴颖.巨泌乳素测定在高泌乳素血症诊断中的临床价值[J].中国卫生检验杂志,2007,17(4):671-671. 被引量:4

二级参考文献16

  • 1George N.KouKoulis:Macroprolactine mia an unnoticeable factor[J].Hormones,2003,2 (2):91-92.
  • 2Mark WJ,Strachan,Weileng Teoh,et al.Donauchope clinical and radiological feature of patients with maroprolactinae mia[J].Clinical Endocrinology,2002,59:339-346.
  • 3Mchael N.Fahine-wilson polyethlene glycol precipitiation as a screening method for macroprolactine mia[J].Clinical Chemistry,1999,45:436-437.
  • 4John R,McDowell I F W,Scanlon M F,et al.Macroprolactin reactivities in prolactin assays:an issue for clinical laboratories and equipment manufacturers[J].Clin Chem,2000,46:884-885.
  • 5Schneider W,Marcowitz S,Al-Shammari S et al.Reactivity of macroprolactin in common automated immunoassays.Clin Biochem 2001,34:469-473.
  • 6Fahie-Wilson M,Brunsden P,Surrey J,et al.Macroprolactin and the roche elecsys prolactin assay:Characteristics of the reaction and detection by precipitation with polyethylene glycol[J].Chin Chem,2000,46:1993-1995.
  • 7Leslie H,Courtney C H,Bell P M,et al.Laboratory and clincal experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method[J].J Clin Endocrinol Metab 2001,86:2743-2746.
  • 8Fahie Wilson M N,Soule S G.Macroprolactin:contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol[J].Ann Clin Biochem,1997,34:252-258.
  • 9Amadori P,Dilberis C,Marcolla A,et al.Macroprolactinemia:predictability on clinical basis and detection by PEG precipitation with two different immunometric methods[J].J Endocrinol Invest,2003,26(2):148-156.
  • 10Fahie-Wilson M N.Polyethylene glycol precipitation as a screening method for macroprolactinemia[J].Clin Chem,1999,45:436-437.

共引文献6

同被引文献41

  • 1Fahie Wilson M, Brunsden P, Surrey J, et al. Macroprolactin and the Roche Elecsys prolactin assay characteristics of the reaction and detection by precipitation with polyethylene glycol[J]. Clin Chem,2000,46(12) : 1993-1995.
  • 2Leslie H, Courtney CH, Bell PM, et al. Laboratory and clinical ex- perience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method[J]. J Clin Endo- crinol Metab,2001,86(6):2743-2746.
  • 3Amadori P, Dilberis C, Marcolla A, et al. Macroprolactinemia: pre- dictability on clinical basis and detection by PEG precipitation with two different immunometric methods[J]. J Endocrinol In- ves,2003,26(2) 148-156.
  • 4McKerma TJ. Should macroprolactin be measured in all hyperpro lactinaemic sera? [J]. Clin Endoerinol ( Oxf), 2009, 71 ( 4 ) : 466 -469.
  • 5Fahie Wilson M, Brunsden P, Surrey J,et al. Macropro-lactin and the roche elecsys prolactin assay:Characteris-tics of the reaction and detection by precipitation with po-lyethylene glycol[J]. Chin Chem,2000,46:1993-1995.
  • 6Leslie H, Courtney C H,Bell P M, et al. Laboratory andclinical experience in 55 patients with macroprolactinemiaidentified by a simple polyethylene glycol precipitationmethod[J], J Clin Endocrinol Metab,2001,86 ;2743-2746.
  • 7Amadori P,Dilberis C, Marcolia A, et al. Macropro-lactinemia:predictability on clinical basis and detectionby PEG precipitation with two different immunometricmethods[J]. J Endocrinol Invest, 2003,26(2):148-156.
  • 8Me Kerma T J. Should macroprolactin be measured in allhyperprolactinaemic sera? [ J]. Clin Endocrinol (Oxf),2009,71(4):466-469.
  • 9Michael FM, Penelope B, John S, et al. Macroprola- ctin and the Roche Elecsys prolactin assay: character- istics of the reaction and detection by precipitation with polyethylene glycol [J]. Chin Chem, 2000, 46 (12) : 1993-1995.
  • 10Macroprolaetinemia VS. Risk of misdiagnosis and mi- smanagement in hyperprolactinemia[J]. Lakartidnin- gen, 2004,101 (6) .. 458-465.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部